SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

PRA Health Sciences, Inc. – ‘8-K’ for 4/28/21

On:  Wednesday, 4/28/21, at 4:06pm ET   ·   For:  4/28/21   ·   Accession #:  1613859-21-13   ·   File #:  1-36732

Previous ‘8-K’:  ‘8-K’ on 4/16/21 for 4/12/21   ·   Next:  ‘8-K’ on 5/17/21 for 5/13/21   ·   Latest:  ‘8-K’ on / for 7/1/21

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/28/21  PRA Health Sciences, Inc.         8-K:2,9     4/28/21   13:476K

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     29K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     99K 
 9: R1          Document and Entity Information Document            HTML     48K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- prah-20210428_htm                   XML     22K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.CAL  XBRL Calculations -- prah-20210428_cal               XML      7K 
 5: EX-101.DEF  XBRL Definitions -- prah-20210428_def                XML     52K 
 6: EX-101.LAB  XBRL Labels -- prah-20210428_lab                     XML    106K 
 7: EX-101.PRE  XBRL Presentations -- prah-20210428_pre              XML     52K 
 3: EX-101.SCH  XBRL Schema -- prah-20210428                         XSD     12K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               17±    25K 
13: ZIP         XBRL Zipped Folder -- 0001613859-21-000013-xbrl      Zip     32K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  prah-20210428  
 i 0001613859 i false00016138592021-04-282021-04-28

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM  i 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date Earliest Event reported):
 i April 28, 2021
   
 i PRA Health Sciences, Inc.
(Exact name of registrant as specified in its charter)
 
 
 i Delaware i 001-36732 i 46-3640387
(State or other jurisdiction
of incorporation)
(Commission File Number)(IRS Employer Identification No.)
   i 4130 ParkLake Avenue
 i Suite 400
 i Raleigh,  i NC  i 27612
( i 919)  i 786-8200
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each className of exchange on which registeredTrading symbol
 i Common Stock $0.01 par value i Nasdaq Global Select Market i PRAH
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 i Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 



Item 2.02 Results of Operations and Financial Conditions.
 
On April 28, 2021, the Company issued a press release announcing the results of the Company’s operations for the quarter ended March 31, 2021.  The press release is furnished as Exhibit 99.1 to this Report and is hereby incorporated by reference in this Item 2.02. 

As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 to this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall either be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.
 
ExhibitDescription of Document
99.1
104Cover Page formatted in Inline XBRL

Signatures
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.
 
PRA Health Sciences, Inc.
Date: April 28, 2021By:/s/ Michael J. Bonello
Name:Michael J. Bonello
Title:Executive Vice President and Chief Financial Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:4/28/214,  DEFM14A
3/31/2110-Q,  425
 List all Filings 
Top
Filing Submission 0001613859-21-000013   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 10:12:47.2pm ET